EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The protective effect of Schisandrin C against methicillin-resistant Staphylococcus aureus -induced otitis media

Weifang Sun iD, Meihui Tian, Xingye Wang, Shuang Jiang, Mengli Jin, Yan Wang, Yating Tang, Shuyue Zhu, Wenlu Liao, Xueying Ding, Xuanyu Lv, Huan Liu und 3 weitere

Antimicrobial Agents and Chemotherapy · 01.07.2026 · 70 (7)

DOI: 10.1128/aac.00095-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 01.07.2026. Verfasst von Weifang Sun und 14 weiteren Autor:innen. Beteiligte Einrichtung: Traditional Chinese Medicine College, Changchun University of Chinese Medicine, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Lignans, Polycyclic Compounds, Methicillin-Resistant Staphylococcus aureus, Otitis Media. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Outstanding Young Discipline Backbone Training Program Grant of Changchun University of Chinese Medicine, the Jilin Provincial Department of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen in otitis media (OM), including acute otitis media (AOM) and chronic suppurative otitis media (CSOM), presenting considerable therapeutic challenges due to its biofilm formation, host immune evasion, and promotion of persistent inflammation. This study evaluated the therapeutic potential of Schisandrin C (Sch C), a natural lignan derived from Schisandra chinensis , in mitigating MRSA-induced OM. In rat models of MRSA-induced AOM and CSOM, Sch C significantly reduced bacterial load and inflammatory responses by decreasing pro-inflammatory cytokine levels. By upregulating tight junction protein ZO-1 and downregulating mucin MUC5B, it also restored epithelial barrier integrity. In addition, Sch C treatment improved auditory function. Mechanistic studies revealed that Sch C directly inhibited sortase A (SrtA), a key enzyme responsible for anchoring surface virulence factors in MRSA, by binding to its active site and inhibiting its transpeptidase activity (fluorescence resonance energy transfer IC₅₀ = 38.68 µM). Through inhibiting SrtA, Sch C disrupted MRSA adhesion, invasion, and biofilm formation without exerting direct bactericidal effects. Furthermore, Sch C synergized with ofloxacin, enhancing its efficacy against MRSA otitis by reducing bacterial load, inflammation, and tissue damage. Collectively, these findings establish Sch C as a potent S. aureus SrtA inhibitor, highlighting its promise as a therapeutic strategy for MRSA-induced OM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LignansPolycyclic CompoundsMethicillin-Resistant Staphylococcus aureusOtitis MediaAnti-Bacterial AgentsStaphylococcal InfectionsAnimalsCyclooctanesRatsBacterial ProteinsBiofilmsAminoacyltransferasesCysteine EndopeptidasesRats, Sprague-DawleyMale

Stichwörter der Autor:innen

MRSASchisandrin Cantivirulencebiofilmotitis mediasortase A inhibitor

Substanzen

LignansPolycyclic CompoundsCyclooctanesAnti-Bacterial AgentsBacterial Proteinsschizandrin Csortase AAminoacyltransferasesCysteine Endopeptidases

Autor:innen und Institutionen

  • Traditional Chinese Medicine College, Changchun University of Chinese Medicine, Changchun, Jilin, China.
  • Department of Traditional Chinese Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, Zhejiang, China.
  • School of Health Management, Changchun University of Chinese Medicine, Changchun, China.
  • School of Basic Medical Science, Changchun University of Chinese Medicine, Changchun, China.
  • College of Integrated Chinese and Western Medicine, Changchun University of Chinese Medicine, Changchun, China.
  • School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun, China.

ORCID-Profile: Weifang Sun, Wu Song, Lin Wei, Yong Tang

Förderung

  • Outstanding Young Discipline Backbone Training Program Grant of Changchun University of Chinese Medicine
  • the Jilin Provincial Department of Education

Zitieren

APA

Sun, W., Tian, M., Wang, X., Jiang, S., Jin, M., Wang, Y., Tang, Y., Zhu, S., Liao, W., Ding, X., Lv, X., Liu, H., Song, W., Wei, L., & Tang, Y. (2026). The protective effect of Schisandrin C against methicillin-resistant Staphylococcus aureus -induced otitis media. Antimicrobial Agents and Chemotherapy, 70(7). https://doi.org/10.1128/aac.00095-26

Vancouver

Sun W, Tian M, Wang X, Jiang S, Jin M, Wang Y, et al. The protective effect of Schisandrin C against methicillin-resistant Staphylococcus aureus -induced otitis media. Antimicrobial Agents and Chemotherapy. 2026;70(7). doi:10.1128/aac.00095-26

BibTeX
@article{Sun2026,
  author = {Sun, Weifang and Tian, Meihui and Wang, Xingye and Jiang, Shuang and Jin, Mengli and Wang, Yan and Tang, Yating and Zhu, Shuyue and Liao, Wenlu and Ding, Xueying and Lv, Xuanyu and Liu, Huan and Song, Wu and Wei, Lin and Tang, Yong},
  title = {The protective effect of Schisandrin C against methicillin-resistant Staphylococcus aureus -induced otitis media},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {7},
  doi = {10.1128/aac.00095-26}
}
Kostenlos starten →